Page 28 – Clinical Laboratory int.

Wren laboratories announces advanced NETest 2.0 for neuroendocrine tumour diagnostics

, 19 March 2025/in Product News /by panglobal

Wren Laboratories has officially discontinued their original NETest 1.0 in favour of an AI-enhanced successor. The new liquid biopsy diagnostic offers improved sensitivity and accuracy for monitoring neuroendocrine tumours through an optimised 51-gene mRNA expression algorithm.

Revvity introduces first dried blood spot-validated measles antibody test with CE mark

, 19 March 2025/in Product News /by panglobal

Revvity’s EUROIMMUN has received CE marking for its Anti-Measles Virus ELISA 2.0 (IgG), the first commercial assay validated for dried blood spot (DBS) sample material, addressing a critical gap in measles diagnostics as global cases continue to rise.

Prognostic value of circulating biomarkers in men compared to women presenting with acute chest pain

, 19 March 2025/in Featured Articles, Cardiac Biomarkers /by panglobal

by Dr Gard Myrmel We have known for a while now that the symptoms of acute coronary syndromes can be different for women compared to men. Here, Dr Myrmel discusses how the differences between the sexes also extend to the prognostic value of circulating biomarkers in patients presenting with acute chest pain.

Torrey Pines introduces precision-controlled heating solution for laboratory applications

, 19 March 2025/in Product News /by panglobal

Advanced thermal uniformity capabilities Torrey Pines Scientific has unveiled its WaferPlate programmable heating system, designed specifically for precision temperature control applications. The Model HP90 features exceptional thermal uniformity across its 352.4mm circular aluminium surfatce, maintaining temperature consistency within 1% across the central 304mm area.

Flow photochemistry transforms peptide amidation for pharmaceutical applications

, 18 March 2025/in E-News /by panglobal

The revolutionary UV-150 photochemical reactor, employed alongside Vapourtec’s R-Series flow chemistry system, has enabled significant advancements in peptide modification techniques with potential to reshape pharmaceutical manufacturing.

Sanofi secures €1.5 billion bond issue amid strategic financial positioning

, 18 March 2025/in E-News /by panglobal

Global healthcare company Sanofi has successfully priced a €1.5 billion bond issue, structured across two tranches with different maturity profiles and interest rate mechanisms. The financing move, announced on 5 March 2025, represents a significant capital raising exercise that strengthens the company’s financial position.

Macrotroponin: potential source of cardiac troponin assay interference

, 18 March 2025/in Cardiac Biomarkers, Featured Articles /by panglobal

by PD Dr Angelika Hammerer-Lercher Measurement of cardiac-specific troponin I or T forms is part of the diagnostic pathway to rule in or rule out acute coronary syndromes, such as heart attack, as well as for prognostication of future cardiovascular disease. CLI chatted to Dr Angelika Hammerer-Lercher (Chief Physician and Director of Central Medical Laboratories, […]